Global Biopharmaceuticals Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 1.02 Billion |
 Market Size (Forecast Year) |
USD 2.62 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球生物制药市场，按产品类型（单克隆抗体、重组生长因子、纯化蛋白质、重组蛋白质、重组激素、疫苗、合成免疫调节剂等）、服务（实验室测试、定制测试/客户专有测试、药典和多药典实验室测试）、原材料类型（配方辅料、活性药物成分 (API) 和药典方法 (USP/EP/JP) 基于供应商资格计划支持）、应用（肿瘤学、炎症和传染病、自身免疫性疾病、代谢紊乱、荷尔蒙紊乱、心血管疾病、神经系统疾病等）– 行业趋势和预测到 2030 年。
生物制药市场分析及规模
慢性病的增多和老年人口的增加为生物制药市场的增长开辟了道路。生物制药彻底改变了癌症、自身免疫性疾病和遗传性疾病等慢性病的治疗。它们提供靶向疗法，可以选择性地作用于特定的疾病途径，与传统的小分子药物相比，疗效更高，副作用更少。
Data Bridge Market Research 分析称，2022 年全球生物制药市场规模为 9.156 亿美元，到 2030 年将飙升至 23.3257 亿美元，预计预测期内复合年增长率为 12.40%。这表明，由于全球生物制药市场需求不断增长，单克隆抗体在生物制药市场的产品类型细分市场中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
生物制药市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制 2015-2020） |
|
定量单位 |
收入（百万美元）、销量（单位）和定价（美元） |
|
涵盖的领域 |
按产品类型（单克隆抗体、重组生长因子、纯化蛋白、重组蛋白、重组激素、疫苗、合成免疫调节剂等）、服务（实验室测试、定制测试/客户专有测试、药典和多药典实验室测试）、原材料类型（配方辅料、活性药物成分 (API) 和药典方法 (USP/EP/JP) 基于供应商资格计划支持）、应用（肿瘤学、炎症和传染病、自身免疫性疾病、代谢紊乱、激素紊乱、心血管疾病、神经系统疾病等） |
|
覆盖国家 |
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America |
|
Market Players Covered |
Amgen Inc. (U.S.), Lilly (U.S), Johnson & Johnson Private Limited (U.S.), Sanofi (France), Abbott (U.S), AstraZeneca (U.K.), Amgen Inc. (U.S.), F. Hoffmann-La Roche Ltd., (Switzerland), bioMérieux (France), Novartis AG (Switzerland), Bristol-Myers Squibb Company (U.S.), Novo Nordisk A/S (Denmark), Merck & Co., Inc. (U.S.), GlaxoSmithKline Plc (U.K.), Biogen (U.S.), Bayer AG (Germany) and Pfizer Inc., (U.S.) |
|
Market Opportunities |
|
Market Definition
Biopharmaceuticals, also known as biologic drugs or biologics, are medical products derived from biological sources such as living organisms, cells, or proteins. These drugs are produced using biotechnology processes and play a crucial role in modern healthcare. Biopharmaceuticals have enabled the development of personalized medicine approaches. These drugs can be designed to target specific molecular characteristics of an individual's disease, allowing for tailored treatment strategies based on the patient's unique genetic profile or disease subtype.
Global biopharmaceuticals market Dynamics
Drivers
- Rising demand for biopharmaceuticals
Chronic diseases such as cancer, autoimmune disorders, diabetes, and cardiovascular diseases continue to rise globally. Biopharmaceuticals offer advanced treatment options that specifically target the underlying causes of these complex diseases, providing improved therapeutic outcomes and enhanced patient care.
- Research and development proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop the medical instruments is also bolstering the market growth rate.
- Growing investment for healthcare facilities
Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Opportunities
- Rise in personalized medicine and precision therapeutics
The field of personalized medicine is rapidly evolving, driven by advancements in genomics, molecular diagnostics, and biomarker identification. Biopharmaceutical companies have the opportunity to develop targeted therapies that align with the principles of precision medicine, tailoring treatments to the specific genetic and molecular characteristics of individual patients.
-
Increasing rare diseases and orphan drugs
Orphan drugs, which are developed to treat rare diseases, represent an area of opportunity in the biopharmaceutical market. These conditions often have limited treatment options, creating a demand for innovative therapies. Biopharmaceutical companies can focus on developing targeted biologics for rare diseases, benefiting from regulatory incentives and addressing unmet medical needs.
Restraints
- Underdiagnoses and Lack of Awareness
Xerostomia is often underdiagnosed and underreported, primarily due to a lack of awareness among both healthcare professionals and the general population. Many individuals may not recognize the symptoms or consider them significant enough to seek medical attention. This can hinder the growth of the xerostomia market as it limits the identification and treatment of affected individuals.
Challenges
- Side Effects and Safety Concerns
Some medications used for treating xerostomia or associated conditions may have side effects or interactions that limit their use or pose safety concerns. Additionally, patients with certain medical conditions or those taking multiple medications may have limited treatment options due to potential contraindications or adverse effects.
This global biopharmaceuticals market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global biopharmaceuticals market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In February 2021, Bristol Myers Squibb and The Rockefeller University have announced the signing of a definitive agreement under which Bristol Myers Squibb has been granted a worldwide exclusive licence to develop, manufacture, and market Rockefeller's novel monoclonal antibody ("mAb") duo treatment that neutralises the SARS-CoV-2 virus for COVID therapy or prevention. This innovative treatment combines two monoclonal antibodies (mAbs) that block the SARS-CoV-2 spike protein and neutralise the virus.
- 2023 年 3 月，F. Hoffmann-La Roche Ltd 宣布与礼来公司达成合作，支持开发罗氏的 Elecsys 淀粉样血浆检测 (EAPP)。EAPP 是一种创新的血液检测，旨在促进阿尔茨海默病的早期诊断。
全球生物制药市场范围
全球生物制药市场根据产品类型、服务、原材料、药典方法和应用进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
产品类型
- 单克隆抗体
- 重组生长因子
- 纯化蛋白质
- 重组蛋白
- 重组激素
- 疫苗
- 合成免疫调节剂
- 其他
服务
- 实验室测试、定制测试/客户专有测试
- 药典和多药典实验室测试
原材料类型
- 配方辅料
- 活性药物成分 (API)
- 基于药典方法（USP / EP / JP）的供应商资格认证计划支持
应用
- 肿瘤学
- 炎症和感染性疾病
- 自身免疫性疾病
- 代谢紊乱
- 荷尔蒙失调
- 心血管疾病
- 神经系统疾病
- 其他
全球生物制药市场区域分析/见解
对全球生物制药市场进行了分析，并按产品类型、服务、原材料、药典方法和应用提供了市场规模见解和趋势，如上所述。
全球生物制药市场报告涵盖的国家包括美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区。
北美在全球生物制药市场占据主导地位，因为其拥有强大的医疗设施基础，以及专门针对这些复杂疾病的根本原因的先进治疗方案，为该地区提供了更好的治疗效果和加强的患者护理。
由于政府加大力度提高认识、技术进步不断加快以及对优质医疗服务的需求不断增长，预计亚太地区在 2023 年至 2030 年的预测期内将出现显著增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
全球生物制药市场还为您提供每个国家/地区资本设备医疗支出增长、全球生物制药市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对全球生物制药市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。
竞争格局和全球生物制药市场份额分析
全球生物制药市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
全球生物制药市场的一些主要参与者包括：
- 安进公司 (美国)
- 礼来（美国）
- 强生私人有限公司（美国）
- 赛诺菲（法国）
- 雅培（美国）
- 阿斯利康（英国）
- 安进公司 (美国)
- F. Hoffmann-La Roche Ltd.（瑞士）
- 生物梅里埃（法国）
- 诺华公司（瑞士）
- 百时美施贵宝公司 (美国)
- 诺和诺德公司（丹麦）
- 默克公司（美国）
- 葛兰素史克公司 (英国)
- Biogen（美国）
- 拜耳公司（德国）
- 辉瑞公司（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
